Clinical trial

Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms

NCT06629389

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-28

PhasePHASE2

Study timeline

Study start (actual)2024-11-28Date precision: day

Registry last updated2024-12-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Cannabidiol 100 mg/mlDRUG · verified · RxNorm: cannabidiol 100 MG/ML

cannabidiol 300 mg/mlDRUG

Cannabidiol 400 mg/mlDRUG

PlaceboDRUG

Sponsors & collaborators

Laboratorio Elea Phoenix S.A.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06629389 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.